Partners & Investors
Oligomerix is actively seeking strategic partnerships to accelerate its research.
Value Proposition: Oligomerix is a highly differentiated biopharmaceutical company targeting tau oligomers for treatment and diagnosis of various dementias including Alzheimer’s disease, PSP, FTD, and other neurodegenerative disorders. Because of our differentiated approach, Oligomerix is positioned to become the premier provider of small molecule therapeutic interventions and biomarkers for blocking tau self-association. The Company has developed a platform of assays, tools, a lead and 2nd generation compounds, and know-how that will enable its strategic partner/acquirer to move rapidly through the full development continuum and launch.